S-Nitrosylation in Cardiovascular Disorders: The State of the Art
Biomolecules · 2025
DOI: 10.3390/biom15081073 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2025. Verfasst von Caiyun Mao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Harbin 150040, China. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Protein Processing, Post-Translational, S-Nitrosothiols. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Heilongjiang Provincial Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Protein S-nitrosylation is a selective post-translational modification in which a nitrosyl group is covalently attached to the reactive thiol group of cysteine, forming S-nitrosothiol. This modification plays a pivotal role in modulating physiological and pathological cardiovascular processes by altering protein conformation, activity, stability, and other post-translational modifications. It is instrumental in regulating vascular and myocardial systolic and diastolic functions, vascular endothelial cell and cardiomyocyte apoptosis, and cardiac action potential and repolarization. Aberrant S-nitrosylation levels are implicated in the pathogenesis of various cardiovascular diseases, including systemic hypertension, pulmonary arterial hypertension, atherosclerosis, heart failure, myocardial infarction, arrhythmia, and diabetic cardiomyopathy. Insufficient S-nitrosylation leads to impaired vasodilation and increased vascular resistance, while excessive S-nitrosylation contributes to cardiac hypertrophy and myocardial fibrosis, thereby accelerating ventricular remodeling. This paper reviews the S-nitrosylated proteins in the above-mentioned diseases and their impact on these conditions through various signaling pathways, with the aim of providing a theoretical foundation for the development of novel therapeutic strategies or drugs targeting S-nitrosylated proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
- Department of Typhoid, School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
- Department of Chinese Internal Medicine, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
ORCID-Profile: Caiyun Mao
Förderung
- Heilongjiang Provincial Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Mao, C., Zhao, J., Cheng, N., Xu, Z., Ma, H., Song, Y., & Sun, X. (2025). S-Nitrosylation in Cardiovascular Disorders: The State of the Art. Biomolecules. https://doi.org/10.3390/biom15081073
Vancouver
Mao C, Zhao J, Cheng N, Xu Z, Ma H, Song Y, et al. S-Nitrosylation in Cardiovascular Disorders: The State of the Art. Biomolecules. 2025. doi:10.3390/biom15081073
BibTeX
@article{Mao2025,
author = {Mao, Caiyun and Zhao, Jieyou and Cheng, Nana and Xu, Zihang and Ma, Haoming and Song, Yunjia and Sun, Xutao},
title = {S-Nitrosylation in Cardiovascular Disorders: The State of the Art},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15081073}
}
EUVIMED